These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Biochemical aspects of involuntary movements (author's transl)]. Nakamura S; Kameyama M No To Shinkei; 1981 Dec; 33(12):1177-85. PubMed ID: 7034752 [No Abstract] [Full Text] [Related]
5. [The role of brain dopamine]. Rybakowski J Psychiatr Pol; 1972; 6(3):341-4. PubMed ID: 4560234 [No Abstract] [Full Text] [Related]
6. [Metals in the metabolism of cerebral neurotransmitters. Physiological importance and metal-enzyme topographic relationships]. De Falco FA; Campanella G Acta Neurol (Napoli); 1975; 30(2):121-68. PubMed ID: 240251 [No Abstract] [Full Text] [Related]
7. The role of brain catecholamines in the regulation of ACTH secretion. Van Loon GR Adv Neurol; 1974; 5():479-86. PubMed ID: 4374068 [No Abstract] [Full Text] [Related]
8. Neurohumoral interactions and basal ganglia function and dysfunction. Hornykiewicz O Res Publ Assoc Res Nerv Ment Dis; 1976; 55():269-80. PubMed ID: 12547 [No Abstract] [Full Text] [Related]
9. [Effect of estradiol on content of monoamines and acetylcholine in rat hypothalamus]. Korniushenko NP; Zriakov OM Ukr Biokhim Zh; 1977; 49(4):67-9. PubMed ID: 898319 [TBL] [Abstract][Full Text] [Related]
10. The biochemistry of the basal ganglia and Parkinson's disease. Curzon G Postgrad Med J; 1977 Dec; 53(626):719-25. PubMed ID: 24209 [TBL] [Abstract][Full Text] [Related]
11. Brain monoamine changes in chronic paranoid schizophrenia and their possible relation to increased dopamine receptor sensitivity. Farley IJ; Shannak KS; Hornykiewicz O Adv Biochem Psychopharmacol; 1980; 21():427-33. PubMed ID: 6155058 [No Abstract] [Full Text] [Related]
12. Some remarks concerning the possible role of brain monoamines (dopamine, noradrenaline, serotonin) in mental disorders. Hornykiewicz O J Psychiatr Res; 1974; 11():249-53. PubMed ID: 4282386 [No Abstract] [Full Text] [Related]
13. [Aminoacids transport in the brain (author's transl)]. Piccoli F Riv Patol Nerv Ment; 1974 Aug; 95(4):267-76. PubMed ID: 4157159 [No Abstract] [Full Text] [Related]
14. The clinical physiology of side effects in long-term L-DOPA therapy. Barbeau A Adv Neurol; 1974; 5():347-365. PubMed ID: 4155234 [No Abstract] [Full Text] [Related]
15. [Neurochemical basis for pathological motor activity]. Hole K Tidsskr Nor Laegeforen; 1974 Jan; 94(1):11-7. PubMed ID: 4362478 [No Abstract] [Full Text] [Related]
16. [Monoamine content in different parts of rat brain in terminal states and during the rehabilitation period after resuscitation]. Khachatrian GS; Kazarian KA Zh Eksp Klin Med; 1978; 18(5):20-9. PubMed ID: 751350 [No Abstract] [Full Text] [Related]
17. [The probenecid test. Evaluation in clinical medicine of cerebral metabolism of serotonin and dopamine]. Véron JP; Mérienne L Nouv Presse Med; 1972 Feb; 1(8):537-9. PubMed ID: 4258943 [No Abstract] [Full Text] [Related]
18. [Biochemical and clinical correlations in Parkinson's disease]. Barbeau A Rev Neurol (Paris); 1972 Aug; 127(2):253-64. PubMed ID: 4603361 [No Abstract] [Full Text] [Related]
19. The effect of prolonged lithium treatment on the synthesis rate and turnover of monoamines in brain regions of rats. Ho AK; Loh HH; Craves F; Hitzemann RJ; Gershon S Eur J Pharmacol; 1970 Apr; 10(1):72-8. PubMed ID: 5458987 [No Abstract] [Full Text] [Related]
20. An update on the neurochemistry of Alzheimer disease. Davies P Adv Neurol; 1983; 38():75-86. PubMed ID: 6137134 [No Abstract] [Full Text] [Related] [Next] [New Search]